94 related articles for article (PubMed ID: 33825289)
21. The Causes Behind the Survival Paradox in Non-Metastatic Colorectal Cancer Patients and its Impact on the Treatment Regimen: A Retrospective Cohort Study.
Zheng P; Xu G; Qin Z; Zhou S; Huang H; Ma D; Gao X
Surgery; 2024 May; ():. PubMed ID: 38760234
[TBL] [Abstract][Full Text] [Related]
22. [Prognosis of rectal cancer patients after total mesorectal excision].
Pan ZZ; Ding PR; Wan DS; Li LR; Wu XJ; Lu ZH; Kong LH; Lin JZ; Zhou ZG
Ai Zheng; 2009 Sep; 28(9):903-7. PubMed ID: 19728904
[TBL] [Abstract][Full Text] [Related]
23. Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers.
Peng JJ; Cai SJ; Lu HF; Cai GX; Lian P; Guan ZQ; Wang MH; Xu Y
World J Gastroenterol; 2007 Jun; 13(21):3009-15. PubMed ID: 17589956
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of local recurrence and survival after curative rectal cancer surgery: a single institution experience.
Boras Z; Kondza G; Sisljagić V; Busić Z; Gmajnić R; Istvanić T
Coll Antropol; 2012 Dec; 36(4):1355-61. PubMed ID: 23390833
[TBL] [Abstract][Full Text] [Related]
25. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer.
Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG
Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of clinicopathologic features and prognosis in 2414 patients with rectal cancer].
Liu YL; Zhao FL; Wang XS
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Dec; 13(12):913-6. PubMed ID: 21186411
[TBL] [Abstract][Full Text] [Related]
27. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy exacerbates the survival paradox of colon cancer: a propensity score matching analysis.
Tian M; Zhou Z
Transl Cancer Res; 2022 Dec; 11(12):4241-4253. PubMed ID: 36644182
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing recurrence of stage I-III rectal cancer in regional Australia.
Haggstrom L; Kang S; Winn R; Putnis S; Nasser E; Chen J; Aghmesheh M; Brungs D
ANZ J Surg; 2020 Dec; 90(12):2490-2495. PubMed ID: 32729654
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of preoperative radiotherapy in stage II and III rectal cancer patients: A Strobe-compliant study of SEER 18 registries database (1988-2011).
Wang R; Zhao D; Liu YJ; Ye C; Qian JR; Dai JN; Liu SY; Liu JY; Li B; Wang MJ; Ping J
Neoplasma; 2019 Nov; 66(6):995-1001. PubMed ID: 31305123
[TBL] [Abstract][Full Text] [Related]
31. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
33. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
34. Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study.
Mo S; Dai W; Xiang W; Huang B; Li Y; Feng Y; Li Q; Cai G
J Cancer; 2018; 9(8):1466-1475. PubMed ID: 29721057
[No Abstract] [Full Text] [Related]
35. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
36. The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres.
Baqar AR; Wilkins S; Staples M; Angus Lee CH; Oliva K; McMurrick P
Int J Surg; 2019 Apr; 64():10-15. PubMed ID: 30822523
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of lymph node ratio staging system in stage III( rectal cancer following 30 Gy/10 f preoperative radiotherapy].
Wang L; Li Z; Li M; Peng Y; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):990-6. PubMed ID: 25341906
[TBL] [Abstract][Full Text] [Related]
38. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
39. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.
Naruke T; Tsuchiya R; Kondo H; Asamura H
Ann Thorac Surg; 2001 Jun; 71(6):1759-64. PubMed ID: 11426744
[TBL] [Abstract][Full Text] [Related]
40. Identification of Recurrence-Predictive Indicators in Stage I Colorectal Cancer.
Lee JH; Lee JL; Park IJ; Lim SB; Yu CS; Kim JC
World J Surg; 2017 Apr; 41(4):1126-1133. PubMed ID: 27872975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
